Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. has 2 licensing announcements in this dataset, dated 2026-08-18 to 2026-09-29.
- Country / operating region
- Japan
- Ticker
- 4519.T
- Headquarters
- Tokyo, Japan
- Founded
- 1925
- Business
- Pharmaceutical research, development, manufacturing, sale, importation and exportation
- Website
- www.chugai-pharm.co.jp
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| AID351 | Dengue virus | antibody | 查無 | 2026-08-18 |
| SPYK04 | RAF-MEK | small molecule | 查無 | 2026-09-29 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | GSK | AID351 | 查無 | 查無 | 查無 | 查無 | — |
| 2026-09-29 | InxMed (Hong Kong) Limited | SPYK04 | 查無 | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| GSK | Worldwide | Royalties based on future product sales and a percentage of sublicensing income from third parties; rates not disclosed. |
| InxMed (Hong Kong) Limited | Worldwide | Royalties based on sales following product launch plus a share of nonroyalty income from sublicensees; rates not disclosed. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無